AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016
Mar 17, 2016
30583_dirs_2016-03-17_843f5db9-e0c8-40de-a73e-7b5361e9c066.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-03-15
Reporting Person: BAFFI ROBERT (EVP, Technical Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-15 | Common Stock | A | 16190 | — | Acquired | 138626 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-15 | Stock Option (Right to buy) Common Stock | $83.43 | A | 36280 | Acquired | 2026-03-14 | Common Stock (36280) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 31676 | Indirect |
Footnotes
F1: Restricted stock units granted March 15, 2016. Price not applicable.
F2: Option grant vests 12/48th on March 15, 2017 and 1/48th on the 15th day of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19